Ubs Group Ag Oncocyte Corp Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.2 - $0.35 $4,977 - $8,710
24,886 Added 132.11%
43,723 $10,000
Q1 2023

May 12, 2023
SELL
$0.2 - $0.49 $3,595 - $8,808
-17,977 Reduced 48.83%
18,837 $6,000
Q4 2022

Feb 08, 2023
BUY
$0.25 - $15.6 $2,809 - $175,328
11,239 Added 43.95%
36,814 $11,000
Q3 2022

Nov 10, 2022
BUY
$0.76 - $15.98 $4,232 - $88,992
5,569 Added 27.84%
25,575 $19,000
Q2 2022

Aug 10, 2022
BUY
$0.86 - $1.53 $989 - $1,759
1,150 Added 6.1%
20,006 $18,000
Q1 2022

May 16, 2022
SELL
$1.15 - $2.25 $17,723 - $34,677
-15,412 Reduced 44.97%
18,856 $28,000
Q4 2021

Feb 14, 2022
BUY
$2.04 - $3.59 $9,275 - $16,323
4,547 Added 15.3%
34,268 $74,000
Q3 2021

Nov 15, 2021
SELL
$3.53 - $5.89 $60,207 - $100,459
-17,056 Reduced 36.46%
29,721 $105,000
Q2 2021

Aug 13, 2021
SELL
$3.77 - $6.0 $28,550 - $45,438
-7,573 Reduced 13.93%
46,777 $268,000
Q1 2021

May 12, 2021
BUY
$2.39 - $6.5 $44,556 - $121,179
18,643 Added 52.21%
54,350 $282,000
Q4 2020

Feb 11, 2021
BUY
$1.38 - $2.63 $4,500 - $8,576
3,261 Added 10.05%
35,707 $86,000
Q3 2020

Nov 12, 2020
SELL
$1.2 - $1.89 $13,726 - $21,619
-11,439 Reduced 26.07%
32,446 $45,000
Q2 2020

Jul 31, 2020
BUY
$1.91 - $3.45 $3,319 - $5,996
1,738 Added 4.12%
43,885 $83,000
Q1 2020

May 01, 2020
SELL
$1.76 - $3.02 $23,272 - $39,933
-13,223 Reduced 23.88%
42,147 $103,000
Q4 2019

Feb 14, 2020
BUY
$1.51 - $2.27 $18,669 - $28,066
12,364 Added 28.75%
55,370 $124,000
Q3 2019

Nov 14, 2019
BUY
$1.59 - $2.51 $25,371 - $40,052
15,957 Added 58.99%
43,006 $91,000
Q2 2019

Aug 14, 2019
BUY
$2.49 - $5.45 $11,471 - $25,108
4,607 Added 20.53%
27,049 $68,000
Q1 2019

May 14, 2019
BUY
$1.47 - $5.91 $30,343 - $121,994
20,642 Added 1146.78%
22,442 $88,000
Q4 2018

Feb 14, 2019
BUY
$1.38 - $2.59 $2,484 - $4,662
1,800 New
1,800 $2,000
Q3 2018

Nov 14, 2018
SELL
$2.2 - $3.45 $816 - $1,279
-371 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$2.0 - $3.3 $11,004 - $18,156
-5,502 Reduced 93.68%
371 $1,000
Q1 2018

May 15, 2018
BUY
$1.25 - $4.6 $836 - $3,077
669 Added 12.86%
5,873 $12,000
Q4 2017

Feb 14, 2018
BUY
$3.9 - $7.4 $18,088 - $34,321
4,638 Added 819.43%
5,204 $24,000
Q3 2017

Nov 14, 2017
SELL
$4.55 - $7.55 $5,860 - $9,724
-1,288 Reduced 69.47%
566 $4,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,752 Added 1717.65%
1,854 $10,000
Q1 2017

Nov 14, 2017
BUY
N/A
102
102 $1,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
399K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $238M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email